Edto, Fahmia .

HRN: 20-46-80  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/21/2025
CEFTRIAXONE 1G (VIAL)
02/21/2025
02/28/2025
IV
700mg
Q 24
T/C AGE; R/O Typhoid Fever
Waiting Final Action 
02/25/2025
MUPIROCIN 2%, 15G (TUBE)
02/25/2025
03/04/2025
TOPICAL
0.5mg
BID
X7 Days
Waiting Final Action 
02/26/2025
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
02/26/2025
03/05/2025
PO
3ml
BID
PCAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: